Influenza Medication Market By Drug Type (Antiviral Drugs {Neuraminidase Inhibitors, Endonuclease Inhibitors, Adamantanes}, Combination Therapies, Adjunctive Therapies, Other), By Route of Administration (Oral, Inhalation, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Clinics & Government Supply Programs), By End-User (Hospitals & Clinics, Homecare Settings, Research & Academic Institute), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Drug Type

• Antiviral Drugs
  • Neuraminidase Inhibitors
  • Endonuclease Inhibitors
  • Adamantanes
• Combination Therapies
• Adjunctive Therapies
• Other

By Route of Administration

• Oral
• Inhalation
• Injectable

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Clinics & Government Supply Programs

By End-User

• Hospitals & Clinics
• Homecare Settings
• Research & Academic Institutes

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Sanofi
• GSK plc
• F. Hoffmann-La Roche Ltd
• CSL Seqirus
• NATCO Pharma Limited
• Scinai Immunotherapeutics Ltd.
• Daiichi Sankyo Company, Ltd.
• Genentech, Inc.
• Novartis AG
• Merck & Co., Inc.
• Johnson & Johnson
• AstraZeneca
• Bayer AG
• AbbVie Inc.
• Eli Lilly and Company